Heterogenous relapse and efficacy endpoint definitions for neuromyelitis optica spectrum disorder studies: A systematic review.

Rebeka Bustamante RochaFernanda Ferreira BomtempoAna Claudia Benevides TadinacGabriela Abrahao AllioniGuilherme Diogo SilvaJoão Paulo Mota Telles

Published in: Multiple sclerosis and related disorders (2024)

Publications were heterogeneous in measuring efficacy, with different use of endpoints and relapse definitions. Standardization across studies would improve data analysis and application in clinical practice.

Keyphrases

data analysis
spectrum disorder
clinical practice
case control
free survival